Institute of Cancer Research

Funded awards at Institute of Cancer Research.

Funded awards
622
Published Funding
£139.4M
Active funded awards
104

Amounts are published for 215 of 622 funded awards — most grants here do not disclose funding. Data as of 16 July 2026.

See funded awards Open the Map

The biggest topic here is Cancer — 413 grants (66%). The busiest year was 2011, with 53 grants.

Funded Awards by Year

View data table
YearFunded awards
200628
200745
200835
200931
201027
201153
201227
201329
201421
201531
201622
201727
201836
201927
202031
202130
202229
202336
202433
202516

Grants

DTP Bid Led by Institute of Cancer ResearchInstitute of Cancer ResearchMRC£7.6M2022Active
Development of MRI-guided radiation therapyInstitute of Cancer ResearchMRC£6.6M2015Completed
FAST-Forward Boost: A randomised clinical trial testing a 1-week course of curative simultaneous integrated boost radiotherapy against a standard 3-week schedule in patients with early breast cancerInstitute of Cancer ResearchNIHR£3.9M2024Active
Negative feedback and oncogene signalling in leukaemia.Institute of Cancer ResearchWellcome£3.1M2014Completed
Preclinical and Clinical Development of BRAF Inhibitors.Institute of Cancer ResearchWellcome£3.0M2011Completed
Combination chemotherapy versus Bacillus Calmette-Guérin (BCG) for high-risk non-muscle invasive bladder cancer– a phase III multi-centre randomised controlled trial (COBRA)Institute of Cancer ResearchNIHR£2.9M2025Active
When DNA becomes its own enemy: How DNA impacts replication dynamics, fidelity, and integrityInstitute of Cancer ResearchWellcome£2.9M2024Active
ICF: Molecular mechanisms of the ADP-ribosyltransferase tankyrase in normal and disease signallingInstitute of Cancer ResearchMRC£2.5M2025Active
Enhancing antitumor immunity by triggering immunogenic cell death with RIPK1 degraders?Institute of Cancer ResearchMRC£2.3M2024Active
Integration of the PRODICT test into the prostate cancer risk pathwayInstitute of Cancer ResearchNIHR£2.0M2024Active
A communal focussed ion beam scanning electron microscope (FIB-SEM) for in situ structural biologyInstitute of Cancer ResearchBBSRC£1.5M2025Active
Regulation of splicing and SNORDs pathways by the Intron-binding complexInstitute of Cancer ResearchBBSRC£1.4M2024Active
Nanopore-Enabled STructure detection (NEST): High Resolution Genome-wide Mapping of DNA Secondary StructuresInstitute of Cancer ResearchBBSRC£932K2025Active
Investigating the roles of H3K14 and H3K18 acetylations in controlling gene expression and cell phenotypeInstitute of Cancer ResearchBBSRC£895K2025Active
Unravelling SWI/SNF ARID1A/B paralogs function at sequence resolutionInstitute of Cancer ResearchBBSRC£892K2024Active
Elucidating the role ART1 in radiotherapy-induced immune resistance in non-small cell lung cancer and head and neck cancerInstitute of Cancer ResearchMRC£597K2026Active
How does the cell assemble the mitotic trigger?Institute of Cancer ResearchMRC£587K2025Active
SONY-ID7000 Spectral Cell Analyser to transform our understanding of tumour evolution and the immune responseInstitute of Cancer ResearchMRC£506K2025Completed
Activation of the HIF pathway as a therapeutic strategy in acute myeloid leukaemiaInstitute of Cancer ResearchMRC£486K2025Active
Minimising side effects of Anaplastic Lymphoma Kinase (ALK) inhibitors for neuroblastoma by elimination of off-target activityInstitute of Cancer ResearchMRF£303K2026Active

Page 1 of 3